Stefano Amadesi

Increased <i>bla</i> _KPC Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate

Paolo Gaibani, Gabriele Bianco, Stefano Amadesi et al. · Antimicrobial Agents and Chemotherapy · 2022 · 40 citations · Full text

Dynamic evolution of imipenem/relebactam resistance in a KPC-producing <i>Klebsiella pneumoniae</i> from a single patient during ceftazidime/avibactam-based treatments

Paolo Gaibani, Federica Bovo, Linda Bussini et al. · Journal of Antimicrobial Chemotherapy · 2022 · 37 citations

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria

Marta Palombo, Federica Bovo, Stefano Amadesi et al. · Antibiotics · 2023 · 25 citations · Full text

Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient

Paolo Gaibani, Stefano Amadesi, Tiziana Lazzarotto et al. · Journal of Global Antimicrobial Resistance · 2022 · 23 citations · Full text

Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient

Paolo Gaibani, Milo Gatti, Matteo Rinaldi et al. · International Journal of Infectious Diseases · 2021 · 21 citations · Full text